Skip to main content
. 2013 Jul;6(4):269–293. doi: 10.1177/1756283X13479826

Figure 2.

Figure 2.

Enzyme-linked immunosorbent assay (ELISA). Although most commonly used for measuring antitumor necrosis factor α (TNF) levels and antidrug antibodies, ELISA has methodologic limitations that include risk of false-positive results because of nonspecific binding to immunoglobulins, and serum levels of the respective anti-TNF may interfere with the assay and produce inconclusive results potentially leading to underestimation of antidrug antibody levels.